Suchergebnisse - "Young, Guy"

PubPharm (18)

1

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7) : primary analysis of a phase 3b open-label trial

enthalten in: Blood | 2024

von Pipe, S. | Collins, P. | Dhalluin, C. | +15

CommentIn: Blood. 2024 Apr 4;143(14):1317-1318. - PMID 38573607

2

Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B) : 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Coppens, M. | Pipe, S. | Miesbach, W. | +36

3

Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH) : a multicentre, open-label, randomised phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Young, G. | Srivastava, A. | Kavakli, K. | +12

CommentIn: Lancet. 2023 Apr 29;401(10386):1400-1401. - PMID 37003290

4

The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A

enthalten in: Blood advances | 2023

von Male, C. | Königs, C. | Dey, S. | +5

5

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

enthalten in: The New England journal of medicine | 2023

von Pipe, S. | Leebeek, F. | Recht, M. | +35

CommentIn: N Engl J Med. 2023 May 18;388(20):1918. - PMID 37195960

6

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

enthalten in: The New England journal of medicine | 2023

von von Drygalski, A. | Chowdary, P. | Kulkarni, R. | +65

7

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2022

von Pipe, S. | Hermans, C. | Chitlur, M. | +28

8

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

enthalten in: Blood | 2021

von Callaghan, M. | Negrier, C. | Paz-Priel, I. | +17

CommentIn: Blood. 2021 Apr 22;137(16):2135-2136. - PMID 33885708

9

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors : HAVEN 1 Study

enthalten in: Thrombosis and haemostasis | 2021

von Schmitt, C. | Adamkewicz, J. | Xu, J. | +6

10

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation

enthalten in: Journal of thrombosis and haemostasis : JTH | 2020

von Young, G. | Lensing, A. | Monagle, P. | +26